Dr. Arlene Sharpe on the Discovery and Further Use of the PD-L1 Pathway
Dr. Arlene Sharpe on the Role of the PD-1 Pathway
Arlene Sharpe | Armenise-Harvard Symposium 2016
Discovering the PD-1 Checkpoint: Winners of the 2014 William B. Coley Award for Tumor Immunology
Dr. Sharpe helping and teaching overseas
Arlene Sharpe is an American immunologist and George Fabyan Professor of Comparative Pathology at Harvard Medical School. In 2017, she received the Warren Alpert Foundation Prize with Gordon Freeman, Lieping Chen, James P. Allison and Tasuku Honjo for their collective contributions to the pre-clinical foundation and development of immune checkpoint blockade, a novel form of cancer therapy that has transformed the landscape of cancer treatment. She served as the hundredth president of the American Association of Immunologists from 2016 to 2017 and served as an AAI Council member from 2013 to 2016. She is the Co-Director of the Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham and Women’s Hospital.
Explore contextually related video stories in a new eye-catching way. Try Combster now!